Related Experiment Videos

The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis

C L Chao1, H H Tsai, C M Lee

  • 1Department of Internal Medicine (Cardiology), National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, Taiwan, ROC.

Atherosclerosis
|November 24, 1999
PubMed

Insights

Elevated homocysteine (HCY) levels, not MTHFR gene variants, are linked to increased coronary artery disease (CAD) risk and severity in Taiwanese adults. Hyperhomocysteinemia shows a graded effect on CAD, but MTHFR homozygosity is not a significant genetic risk factor.

Area of Science:

  • Cardiovascular Genetics
  • Nutritional Biochemistry
  • Epidemiology

Background:

  • Methylenetetrahydrofolate reductase (MTHFR) gene variations and elevated plasma homocysteine (HCY) are implicated in cardiovascular disease.
  • The specific impact of MTHFR genotypes and HCY on coronary atherosclerosis severity in Asian populations remains unclear.

Purpose of the Study:

  • To investigate the association between MTHFR genotypes, plasma HCY concentrations, and coronary artery disease (CAD) in a Taiwanese population.
  • To determine the relationship between these factors and the severity and extent of coronary atherosclerosis.

Main Methods:

  • Genotyping for MTHFR polymorphisms and measurement of plasma HCY levels in 192 Taiwanese individuals (116 with CAD, 76 without).
  • Statistical analysis to compare genotype frequencies and HCY levels between CAD patients and controls.
  • Correlation analysis to assess the relationship between HCY levels and atherosclerosis severity/extent.

Main Results:

  • MTHFR genotype distribution was similar between CAD patients and controls; homozygosity was not a significant risk factor.
  • CAD patients exhibited significantly higher plasma HCY levels compared to non-CAD subjects.
  • Elevated HCY levels correlated positively with multi-vessel disease, severe stenotic lesions (> or = 90%), and showed a graded increase in CAD risk across HCY quartiles.
  • HCY concentrations were significantly correlated with both the severity and extent of coronary atherosclerosis.

Conclusions:

  • Hyperhomocysteinemia, rather than MTHFR gene homozygosity, is a significant risk factor for CAD and associated atherosclerosis in this Taiwanese population.
  • Elevated HCY levels demonstrate a dose-dependent effect on CAD risk and atherosclerosis progression.
  • Further research, including vitamin status assessment, is warranted to fully elucidate the MTHFR-CAD relationship.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...